お知らせ

論文がアクセプトされました。”Kanda M, Nagahata K, Moriyama M, Takano K, Kamekura R, Yoshifuji H, Tsuboi H, Yamamoto M, Umehara H, Umeda M, Sakamoto M, Maehara T, Inoue Y, Kubo S, Himi T, Origuchi T, Masaki Y, Mimori T, Dobashi H, Tanaka Y, Nakamura S, Takahashi H and Japanese Study Group for IgG4-related Dacryoadenitis and Sialadenitis, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan. The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis. Mod Rheumatol.”

論文がアクセプトされました。”Yamamoto M, Origuchi T, et al. and Japanese Study Group for IgG4-Related Disease, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan. Clinical Profile of IgG4-Related Disease in Japan based on the Rare Disease Data Registry. Immunol Med.”

論文がアクセプトされました。”Yoshida S, Fujita Y, Koga T, Matsumoto H, Sumichika Y, Saito Y, Sato S, Asano T, Kobayakawa M, Mozokami M, Sugiyama M, Migita K. Identification of novel cytokine to judge the diagnosis and clinical phenotype of adult-onset Still’s disease. Immunol Med.”

中路啓太先生（長崎大学病院）と江藤真実先生（神戸市 隈病院）が第67回日本甲状腺学会学術集会にてロシュ若手奨励賞(YIA)を受賞されました。

論文がアクセプトされました。”Koga T, Sato S, Furukawa K, Yamamoto H, Kawakami A. Investigating the impact of tocilizumab on serum cytokines concentrations in Japanese FMF patients: A sub-analysis of the NUH01FMF study. Immunol Med.”

論文がアクセプトされました。”Tsuji Y, Koga T, Tomokawa T, Umeda M, Iwamoto N, Kawakami A. Efficacy and safety of canakinumab in familial Mediterranean fever in Japan: a single-centre retrospective study. Clin Exp Rheumatol.”

辻 良香先生が2024年度日本シェーグレン症候群学会奨励賞を受賞されました。

論文がアクセプトされました。”Watanabe K, Chiba K, Shiraishi K, Iida T, Iwamoto N, Yonekura A, Kawakami A, Osaki M. Microarchitectural analysis of the metacarpophalangeal joint using HR-pQCT in patients with rheumatoid arthritis: A comparison with healthy controls. Bone.”

論文がアクセプトされました。”Niri T, Inoue S, Akazawa S, Nishikido S, Miwa M, Kobayashi M, Yui K, Okita M, Kawakami A, Abiru N. Essential role of interferon-regulatory factor 4 in regulating diabetogenic CD4+ T and innate immune cells in autoimmune diabetes in NOD mice. Clin Exp Immunol.”

論文がアクセプトされました。”Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Takatsuki K, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H, Japan VEXAS study group. Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry. Rheumatology.”